In a development that has sent shockwaves of optimism through the biotechnology sector, Massachusetts-based Replimune announced on...
Treatment Innovations
STOCKHOLM – The European medical technology and in vitro diagnostics (IVD) industry is currently navigating a period...
Once the darling of the global pandemic response, the German mRNA powerhouse BioNTech is undergoing a profound...
Date: May 26, 2026 Reporting by: Ben Fidler The biopharmaceutical landscape underwent significant shifts this week as...
In the high-stakes world of pharmaceutical development, where the average cost to bring a single new drug...
In a watershed moment for neurotechnology, ABILITY Neurotech has officially received clearance from the Medical Research Ethics...
By Jonathan Gardner Published May 26, 2026 In a milestone that could redefine the standard of care...
The global transcatheter aortic valve replacement (TAVR) market—a multi-billion dollar sector of cardiovascular medicine—is undergoing a significant...
A New Dawn for Hepatitis B: GSK and Ionis’ Bepirovirsen Marks a "Historic Moment" in Viral Treatment
A New Dawn for Hepatitis B: GSK and Ionis’ Bepirovirsen Marks a "Historic Moment" in Viral Treatment
By Editorial Staff Published May 28, 2026 In a development that medical experts are calling a "historic...
By Investigative Desk The Food and Drug Administration (FDA) is facing its most significant leadership crisis in...
